Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by rcash1on Oct 26, 2018 2:28pm
99 Views
Post# 28879388

RE:RE:RE:RE:RE:RE:RE:Next Week

RE:RE:RE:RE:RE:RE:RE:Next WeekFew things to point out . First PUF financing was done strictly for their JV in B.C. . So no $ for the Greece project will be allocated from that financing. Although revenue should start to flow in PUF by the time they’re ready to build out a Greece facility, they also have a very low float + just raised at 2$ . PUF does bring some credibility especially with a attachment to Canopy . Second LIB is up a double on the investment in BLOX ( although it’s peanuts of $ ) and I’m sure once they close the greenhouse acquisition that will be much more . IMO they’ve already allocated $ for NR sales only and that would be the most logical step if applicable with the municipality . It would also secure a sales license and probably be the quickest thing to revenue other then retail . JK phase 2 will be costly and take a while to get sales , by then there might be a supply glut . So that would be be my move, as we’re going to get quickly into a market phase of fundamentals. 25 to 50x earnings for growth stocks would be normal but we need revenue and earnings fast . As the market matures fundamentals will drive SP ,right now we have no fundamentals other then treasury. So as a speculator I know this: we’re not going bankrupt, have enough $ raised to complete NR, JK phase 1 , Pets formulations and possibly a small retail operation. That’s enough avenues to revenue ,execute on a few of them and Liberty will be fine ..Management has been very cautious with that treasury and dilution so far.  If we go back into Bull market territory then that raise could fund JK phase 2 and Greece but really if all the things I listed come to fruition they might be able to fund that with Revenue...  It’s a fine line beteeen being cautious and falling behind . All this is my opinion 
<< Previous
Bullboard Posts
Next >>